Your Board wants to see a strategic plan to develop a promising pre-clinical candidate.

Our approach starts with the final objective and includes:

  • Assessing the technology platform, competitive landscape and freedom to operate

  • Drafting of a pre-clinical and clinical development plan tailored to the indication

  • Establishing the optimal regulatory strategy including risk mitigations

  • Estimating timelines, budget and potential return associated with the development plan

© 2020 by LFSCNC. LFSCNC is the trade name of HDH Consulting BV.